Eurasian Journal of Pulmonology

INVITED REVIEW ARTICLE
Year
: 2019  |  Volume : 21  |  Issue : 1  |  Page : 1--8

How to optimize aerosol drug delivery during noninvasive ventilation: What to use, how to use it, and why?


Arzu Ari 
 Department of Respiratory Care, Texas State University, Texas, USA

Correspondence Address:
Dr. Arzu Ari
Department of Respiratory Care, College of Health Professions, Texas State University, 200 Bobcat Way, Room 214, Round Rock, Texas
USA

Much evidence supports the use of non-invasive ventilation (NIV) in patients who have acute and chronic respiratory failure and aerosolized medications are increasingly used in this patient population. Successful application of aerosol therapy during NIV depends on the effectiveness of the drug deposition in the lungs. Previous evidence showed that many factors impact aerosol delivery to patients receiving NIV. Those factors include mode of ventilation, ventilator parameters, type of ventilator circuit, the position of the aerosol device, the location of leak port, type of exhalation valve, humidity, enhanced condensational growth, type of aerosol device, and interface as well as delivery technique. The purpose of this paper is to review the available evidence related to aerosol therapy during NIV and provide recommendations to optimize aerosol drug delivery to patients receiving NIV.


How to cite this article:
Ari A. How to optimize aerosol drug delivery during noninvasive ventilation: What to use, how to use it, and why?.Eurasian J Pulmonol 2019;21:1-8


How to cite this URL:
Ari A. How to optimize aerosol drug delivery during noninvasive ventilation: What to use, how to use it, and why?. Eurasian J Pulmonol [serial online] 2019 [cited 2019 Aug 18 ];21:1-8
Available from: http://www.eurasianjpulmonol.com/article.asp?issn=2148-5402;year=2019;volume=21;issue=1;spage=1;epage=8;aulast=Ari;type=0